baber/WOPTO huggingface dataset:
Patent NZ-198325-A (NZ)
Title: Telephone line circuit:regulated line current
Inventor: CHEA R C W JR
IPC: H04M19/08
Filed: 1981-09-10
Abstract: A subscriber line interface circuit is described wherein current supplied to a telephone subscriber line from a shared voltage source such as a DC/DC converter is regulated thereby permitting a regulated line current to be supplied to a plurality of line circuits from a single shared voltage source. In accordance with the present invention, both the dc line feed and the ac transmission requirements of a subscriber line interface circuit for a telephone exchange are implemented in a single circuit incorporating ac and dc impedance synthesis techniques. A significant reduction in the heretofore required expensive and bulky discrete components of the subscriber line interface circuit is achieved.
Patent NZ-203065-A (NZ)
Title: Penicillin derivatives and pharmaceutical compositions;intermediates
Inventor: BURTON G
IPC: C07D499/72
Filed: 1983-01-20
Abstract: Preparation and use of 6,alpha-methoxy-6,beta-2-(2-methylphenoxycarbonyl)-2-(thien-3-yl) acetamido penicillanic acid of the formula 
<CHEM>
 or a pharmaceutically acceptable salt or in vivo hydrolysable ester thereof. 
<??>Intermediate of formula (X) 
<CHEM>
 and pharmaceutical composition comprising a penicillin of the first-mentioned formula, optionally with a clavulanic-acid derivative.
Patent NZ-233344-A (NZ)
Title: Method of preparing a freeze-dried pharmaceutical formulation
Inventor: UEDA SEIGO
IPC: A23L3/44
Filed: 1990-04-18
Abstract: In a freeze-drying method for producing a dried pharmaceutical compound or preparation, a first liquid is frozen, a second liquid is added to the frozen first liquid and is frozen thereon, and the frozen first and second liquids are freeze-dried together, in which at least one of said first and second liquids contains said pharmaceutical compound or preparation dissolved or suspended therein. The other liquid or liquids may be pure solvent (generally water) or may contain one or more other substances.
Patent NZ-234227-A (NZ)
Title: Delayed release dosage form
Inventor: KWAN LILIAN
IPC: A61K9/22
Filed: 1990-06-25
Abstract: Veterinary delayed release dosage forms which remain in the rumeno-reticular sac of an animal over an extended period of time and in which the therapeutically active substance has a predictable and delayed release pattern. The compositions comprise a dense filler, a disintegrant and a therapeutically active substance. The dosage form has a hydrophobic polymer or co-polymer coating and can deliver a plurality of doses of a medicament intermittently at a preset time interval in the rumen.
Patent NZ-236461-A (NZ)
Title: Diamino derivatives of phosphinic acid esters or a sulphoxide, and pharmaceutical compositions
Inventor: BUDT KARL-HEINZ
IPC: A61P31/12
Filed: 1990-12-14
Abstract: Cpds. of formula (I) and their salts are new. - A-N(R4)-C(R2)(R3)-Q-C(R2)(R3)-N(R4)-A (I) - where Q = -P(R6)(Y-R5)-, P(R6)(NR7R7) or -S(O)m. Y = O or S. m = 1-2. A, A = -(G)p-(F)o-(E)n-D. E, F, G = a natural or synthetic amino acid, azaamino acid or imino acid. n, o, p = 0 or 1. D = R1, -CO-C(R9)(R10)-NR8-R1, CO-CH(R9)-CH(R11)-R1 or -CO-CH(R9)-O-R1. R1 = H, CO2H, opt. substd. 1-18C alkyl, or -W-R1a, where R1a is the same as R1 and W = CO, CS, OCO, SO2, SO, S, NHSO2, NHCO, CH(OH), N(OH) or CO-V, where V is a peptide residue that is 1-10 amino acids long. R1, together with R11, can form a 5-12 membered mono- or bicyclic satd. or partially unsatd. ring system that may contain an S, SO or SO2 gp. R1 may also be glycosyl (pref. glucofuranosyl or glucopyranosyl), derived from ldotetroses, aldopentoses, aldohexoses, ketopentoses, ketohexoses, deoxyaldoses, aminoaldoses, oligosaccharides and their stereoisomers. R2, R2 = the same as R1 (but is not a glycosyl gp.). R3, R3 - ( P05331)
Patent NZ-236924-A (NZ)
Title: Viterbi receiver: estimating transmission function for each antenna signal
Inventor: BACKSTROM TOMAS OLOF
IPC: H03M13/23
Filed: 1991-01-28
Abstract: Signals in synchronizing sequences and data sequences are transmitted over a fading channel to a Viterbi-receiver (11, 12). The signals are received by antennas and sampled to received antenna signals (sin,r(k)). Part channel estimates (hest,r) for the individual antennas are formed. For Viterbi-analysis, assumed input signals (sa,r( DELTA Tij,k)) for the data sequence are produced with the aid of the part channel estimates (hest,r). Part metric values (mr( DELTA Tij,k)) are formed as a difference between the received antenna signal (s,in,r(k)) and corresponding assumed input signals (sa,r( DELTA  Tij,k)) for Viterbi state transitions ( DELTA Tij). For one state transition there is formed a metric value such as the sum of a metric value ((M(Tj,k-1)) for an old state (Tj) at a preceding sampling time point (k-1) increased with a weighted (Kr) sum of the part metric values (mr( DELTA Tij,k)) belonging to individual part channel estimates (hest,r). Corresponding metric values are formed for all state transitions to the new state (Ti) and the smallest of these metric values is chosen in accordance with the Viterbi-algorithm.
Patent NZ-242352-A (NZ)
Title: Recycling plastics waste by stirring two different thermoplastic polymers or copolymers in such a way as to produce a homogeneous thermoplastic material
Inventor: MARIANI GIORDANO
IPC: B29K105/26
Filed: 1992-04-14
Abstract: The device comprises a cylindrical chamber (2) fitted with a loading hopper (4) and with a discharging well (5). A rotor (6) fitted with blades (31, 32) is driven in rotation by an electric motor (7) via a clutch (18). The chamber (2) and the bearings (22) of the rotor (6) are surrounded by a protective shroud (26). In the chamber (2), a mixture containing at least two different thermoplastic polymers is subjected to stirring (agitation) by the blades (31, 32) of the rotor (6), and this treatment is stopped after the appearance of a rapid increase in the energy consumed. A homogeneous thermoplastic is thus obtained. <IMAGE>
Patent NZ-250649-A (NZ)
Title: Tablet coating by dipping, rotating and drying tablets on carrier plate at a first section and then transferring plates to a similar second section
Inventor: BERTA NORBERT I
IPC: A61J3/06
Filed: 1994-01-07
Abstract: Disclosed is an apparatus for coating product (10) with two colors which includes a first coating section, a second coating section and a means for transferring products from the first to the second sections. The first section includes a feeding (80) and loading station for depositing products onto product holders (30) retained in product carrier plates (50,50'). The products are advanced to a first dipping station in which a vacuum chamber (60) having the plurality of vacuum tubes (100) engages a plate and inverts and dips the products to coat a first portion of the product. The plates are then advanced to a first rotating station where another vacuum chamber and vacuum tube device engages the plates and rotates the plates one revolution for spreading the coating over that first portion. The plates are advanced to an elevator where they are raised incrementally to a dryer (130) that extends over the first section of the coating apparatus. The plates are transferred into the dryer where they traverse through the dryer in a controlled manner for curing the coating applied to the first portion. The plates are transferred to a down elevator and returned to the conveyor where they are advanced to a side to side transfer apparatus. The transfer apparatus transfers the products to the second section of the coating apparatus in such a manner to expose on carrier plates the uncoated portion of the products. The plates are then advanced to identical dipping and rotating stations as in the first section and then transferred by an elevator up to a second dryer located above the conveyor in the second section. The plates traverse the second dryer and are returned to the second conveyor by a down elevator where the plates are advanced to an unloading and discharge apparatus. The empty plates are then advanced to the side to side transfer where they are recycled for future use in the apparatus. <IMAGE>
Patent NZ-306653-A (NZ)
Title: Isolated dna il-17 receptors
Inventor: YAO ZHENGBIN
IPC: C07K14/54
Filed: 1996-03-21
Abstract: Isolated receptors for CTLA-8, DNAs encoding such receptors, and pharmaceutical compositions made therefrom, are disclosed. The isolated receptors can be used to inhibit an immune response.
Patent NZ-318527-A (NZ)
Title: Method for marking objects and objects being marked with such method
Inventor: GUSTAFSSON STIG
IPC: A23G3/56
Filed: 1996-08-20
Abstract: PCT No. PCT/SE96/01027 Sec. 371 Date May 11, 1998 Sec. 102(e) Date May 11, 1998 PCT Filed Aug. 20, 1996 PCT Pub. No. WO97/10162 PCT Pub. Date Mar. 20, 1997Method for marking an object where the object is placed in a package whereby a pattern in said package is caused to make a marking in said object. Objects being marked with the above method. The invention is especially useful for marking solid or semi-solid formulations of drugs, candy and food-stuff. Specifically the invention is useful to mark nicotine-containing chewing gums. Other solid or semi-solid objects can equally well be marked using the present invention.
Patent NZ-337946-A (NZ)
Title: C-13 labelled oligosaccharides and polysaccharides useful as diagnostic agents for pancreatic exocrine function
Inventor: KOHNO TADASHI
IPC: A61K51/06
Filed: 1999-09-21
Abstract: A 13C-labeled oligosaccharide or polysaccharide which is hydrolysable with a-amylase or a salt thereof excluding U-13C-maltose, 13C-starch, 1-13C-maltotetraose, 1-13C-amylose, 13C-heteropolysaccharide poly 54, 13C-lactose, 13C-sucrose and cyclomaltoheptaose derivatives containing 2-O-13C-methyl-glucose, 3-O-13C-methyl-glucose, 6-O-13C-methyl-glucose, 2,3-di-O-13C-methyl-glucose, 2,6-di-O-13C-methyl-glucose or 3,6-di-O-13C-methyl-glucose. A 13C-labeled inclusion complex or a salt thereof comprises a cyclodextrin or modified derivative as a host molecule. A diagnostic agent thereof is useful for pancreatic exocrine function.
Patent NZ-504077-A (NZ)
Title: Electric evaporator for the evaporation of volatile products with variable evaporation effected by adjustable rotatable cap
Inventor: BASAGANAS MILLAN JORDI
IPC: A61L9/03
Filed: 1999-08-19
Abstract: A device to perform evaporation of insecticides, perfumes or the like, wherein the degree of evaporation is controlled by a moving cap (9) which makes up the regulating element (6), which is meant to produce a chimney effect in the upwards motion of the generated vapour, so that this effect enhances evaporation, while regulation is achieved by the different heights at which moving cap (9) can be placed. This displacement is performed manually by moving guide (13) inside inclined track (10)
Patent NZ-505552-A (NZ)
Title: Recirculating linear bearing with retainer
Inventor: LANGE KENNETH
IPC: F16C29/06
Filed: 2000-07-05
Abstract: A traveler comprising a track (4), a car (2) and a bearing retainer (8).  The car comprises a plurality of bearings (16) in a recirculating race having an open portion for bearing removal. The bearings are held in place in use by the bearing retainer (8) which clips into the car (2) at hole (14).
Patent NZ-510301-A (NZ)
Title: Flow through water heater ground fault protection
Inventor: THWEATT CARLISLE
IPC: F24H1/10
Filed: 2000-03-31
Abstract: A hot tub continuous flow water heater includes an electrical heater element 22 mounted by conductive, stray current collecting, elements 28, 30 within the outer polymeric casing 20, and in direct heat transfer contact with the water pumped through the casing from the inlet 16 to outlet 18.  The heating element includes an inner resistive heating conductor and an outer conductive jacket separated by a dielectric material.  A controller 40 supplies power to the inner conductor of the heater and in accordance with the level of ground fault current detected by the ground fault detector 36 in electrical contact with the outer conductive jacket of the heater element.
Patent NZ-511574-A (NZ)
Title: A chemically bound ceramic material consisting of a ceramic based system and used as a dental filling material
Inventor: KRAFT LARS
IPC: A61K6/17
Filed: 1999-10-08
Abstract: A material for a chemically bound ceramic system is described, the binder phase of which essentially consists of a cement based system.  The material comprises one or more expansion compensating additives adapted to give the material dimension stable long time properties.
Patent NZ-512297-A (NZ)
Title: Genes and proteins of group a strep, and their use
Inventor: SANTANGELO JOSEPH DAVID
IPC: A61K48/00
Filed: 1999-12-22
Abstract: A peptide sequence (pho3-1) obtained from a Group B Streptococcus (Streptococcus agalactiae) and its use for treating conditions associated with bacterial infection e.g. urinary tract infection.
Patent NZ-514403-A (NZ)
Title: Fused-ring compounds and use thereof as drugs
Inventor: HASHIMOTO HIROMASA
IPC: C07D403/04
Filed: 2000-12-22
Abstract: A fused ring compound of the formula (I) wherein each symbol is as defined in the specification, a pharmaceutically acceptable salt thereof, and a therapeutic agent for hepatitis C, which contains this compound. The compound shows an anti-hepatitis C virus (HCV) action based on the HCV polymerase inhibitory activity, and is useful as a therapeutic agent or prophylactic agent for hepatitis C.
Patent NZ-514452-A (NZ)
Title: Hard surface treating agent, stain-proofing agent and method for surface treatment
Inventor: OKAMURA KIYOSHI
IPC: C09G1/02
Filed: 2000-11-09
Abstract: A hard surface-treating agent, which comprises titanium oxide of an anatase form, a thermoplastic resin and an organic medium, the titanium oxide and the thermoplastic resin being dispersed in the organic medium, wherein the organic medium is a mixture of an organic solvent and water, the content of the said titanium oxide is within the range of 0.05-20wt% and the content of the thermoplastic resin within the range of 0.05-20%.
Patent NZ-515323-A (NZ)
Title: Purine derivatives substituted by a 5- (hydroxymethyl)tetrahydro-3,4-furandiol
Inventor: MONAGHAN SANDRA MARINA
IPC: C07H19/167
Filed: 2000-10-06
Abstract: A purine derivative or a pharmaceutically acceptable salt or solvate thereof has the formula (I) wherein: R1 is hydrogen or optionally substituted alkyl; A is a bond or alkylene; R2 is (i) hydrogen, alkyl or optionally substituted cycloalkyl, phenyl or naphthyl, with the proviso that R2 is not hydrogen when A is a bond, or (ii) when A is alkylene, R2 is -NR7R8, -OR3, -COOR3, -OCOR4, -SO2R4, -CN, - SO2N(R3)2, -NR3COR4 or -CON(R3)2, or (iii) a C-linked, optionally C-substituted 4 to 11 membered, mono or bicyclic heterocycle having either from 1 to 4 ring nitrogen atom(s) or 1 or 2 nitrogen and 1 oxygen or 1 sulphur ring atoms; R3 is H, alkyl, cycloalkyl or phenyl; R4 is alkyl, cycloalkyl or phenyl; either, R7 and R8, taken together with the nitrogen atom to which they are attached form an optionally substituted azetidinyl, pyrrolidinyl, piperidinyl, morpholinyl, piperazinyl, homopiperidinyl, homopiperazinyl or tetrahydroisoquinolinyl or R7 is H, alkyl, cycloalkyl, phenyl or benzyl and R8 is H, alkyl, cycloalkyl, phenyl, benzyl, fluoroalkyl, -CON(R3)2, -COOR4, alkanoyl or -SO2N(R3)2. The compounds are useful for treating a respiratory disease, septic shock, male erectile dysfunction, hypertension, stroke, epilepsy, cerebral ischemica, peripheral vascular disease, post-ischemic reperfusion injury, diabetes, rheumatoid arthritis, multiple sclerosis, psoriasis, allergic dermatitis, eczema, ulcerative colitis, Crohns disease, inflammatory bowel disease, Heliobacter pylori- gastritis, non-Heliobacter pylori gastritis, non-steroidal anti-inflammatory drug-induced damage to the gastro- intestinal tract or a psychotic disorder, or for wound healing.
Patent NZ-518684-A (NZ)
Title: Use of a peripheral mu opioid antagonist to treat or prevent ileus
Inventor: FARRAR JOHN J
IPC: A61K31/445
Filed: 2000-11-29
Abstract: A peripheral mu opioid antagonist compound such as a piperidine-Nalkylcarboxylate, a quaternary morphinan, an opium alkaloid derivative and a quaternary benzomorphan compound is used in the manufacture of a medicament to treat or prevent ileus. The piperidine-Nalkylcarboxylate can be of the formula (I) or a stereoisomer, prodrug, or pharmaceutically acceptable salt, hydrate or N-oxide thereof wherein: R1 is hydrogen or alkyl; R2 and R4 are independently is hydrogen, alkyl or alkenyl; R3 is hydrogen, alkyl, alkenyl, aryl, cycloalkyl, cycloalkenyl, cycloalkyl or cycloalkenyl- or aryl- substituted alkyl; A is OR5 or NR6R7; n is 0 to 4 and R5, R6 and R7 are as defined in the specification.
Patent NZ-519099-A (NZ)
Title: Method of drying lignocellulose material
Inventor: ERIKSSON LENNART V
IPC: B27N1/00
Filed: 2000-11-16
Abstract: In a method of drying ligno-cellulose fibrous material in two steps in connection with the manufacture of fibreboard, the material is transported with the help of a first drying gas through a first drying line (11) to a first cyclone (13) where the first drying gas is conducted away from the material. Thereafter the material is transported with the help to a second drying gas through a second drying line (17) to a second cyclone (19) where the second drying gas is conducted away while the material is advanced to a subsequent step. The second drying gas, which is conducted away from the second cyclone (19), is moved to the first drying step and used as a portion of the first drying gas. A portion of the first drying gas, which is conducted away from the first cyclone (13), is recycled and used as drying gas at the first drying step.
Patent NZ-519283-A (NZ)
Title: Placental human neurokinin B precursor
Inventor: PAGE NIGEL
IPC: A61K38/00
Filed: 2000-11-10
Abstract: Methods of diagnosing pregnancy induced hypertension or pre-eclampsia by the measurement of the production of neurokinin B, its precursor and fragments thereof are provided, as are kits for use in the methods. Treatments of the conditions and methods of preparing suitable medicaments are also provided, as are antibodies and useful antigenic materials.
Patent NZ-522634-A (NZ)
Title: PRO243 encoding a polypeptide with homology to chordin and antibodies and vectors
Inventor: BAKER KEVIN P
IPC: C12N5/08
Filed: 1998-12-01
Abstract: The nucleic acid sequence comprises the sequence shown in Figure 3 (SEQ ID NO:6) and encodes a polypeptide having the sequence shown in Figure 4 (SEQ ID NO:7), a nucleic acid also comprises the full-length coding sequence of a DNA deposited under accession number ATCC 209508. The polypeptide may mediate embryological development. Host cells and vectors comprising the nucleic acid, processes of producing the polypeptide and antibodies that bind the polypeptide are also described.
Patent NZ-525120-A (NZ)
Title: A framing system and method for forming curved block walls and an interconnecting web member therefor
Inventor: BURKE WILLIAM HUGH
IPC: E04C1/42
Filed: 2003-04-01
Abstract: The web member has male and female ends so that adjacent members may be interlocked and form curved block walls.
Patent NZ-525133-A (NZ)
Title: Medium access control for orthogonal frequency-division multiple-access (OFDMA) cellular networks
Inventor: LIU HUI
IPC: H04W28/04
Filed: 2001-10-10
Abstract: A method and apparatus for controlling OFDMA cellular networks is described. In one embodiment, the method comprises receiving channel characteristics and noise-plus-interference information measured at spatially distributed subscribers and assigning traffic channels for an orthogonal frequency-division multiple-access (OFDMA) network.
Patent NZ-528160-A (NZ)
Title: Monoclonal antibody specific for an epitope of inactivated feline immunodeficiency-encoded glycoprotein
Inventor: HUANG CHENGJIN MICHAEL
IPC: C12N15/02
Filed: 2003-09-11
Abstract: A monoclonal antibody specific for an epitope unique to an inactivated FIV-encoded glycoprotein is described with FIV being either FIV-Shiz or FIV-Petaluma, and the glycoprotein being gp95 or gp130. A method for the detection of an epitope unique to an inactivated FIV-encoded glycoprotein in a sample is also disclosed. This comprises contacting the sample with a monoclonal antibody specific for an epitope unique to an inactivated FIV-encoded glycoprotein to form a complex, and detecting the complex. Also described are methods for determining the quantity and potency of an inactivated FIV in a sample, as well as a method for the preparation of monoclonal antibodies specific for an epitope unique to an inactivated FIV-encoded glycoprotein.
Patent NZ-529644-A (NZ)
Title: Network bandwidth control
Inventor: KURDZINSKI ANDREW EDWARD
IPC: H04L12/56
Filed: 2002-05-17
Abstract: A system for controlling the bandwidth allocated to a network connection between two nodes includes a means for receiving the bandwidth change request, a means for generating control commands to control a plurality of network elements of the network connection in order to satisfy the change request and a means for sending the commands to the network elements.
Patent NZ-532161-A (NZ)
Title: Use of cmc in processed meat products
Inventor: BOEVINK FRANS H M
IPC: A23L17/00
Filed: 2002-10-08
Abstract: The use of carboxymethyl cellulose (CMC) in processed meat products, such as beef, pork, fish or poultry, wherein the CMC is characterized by forming a gel at 25 degree C after high shear dissolution in a 0.3 wt% aqueous sodium chloride solution, the final content of the CMC in the aqueous sodium chloride solution being 1 wt% for a CMC having a degree of polymerization (DP) of >4,000, 1.5 wt% for a CMC having a DP of 3,000-4,000, 2 wt% for a CMC having a DP of 1,500-<3,000, and 4 wt% for a CMC having a DP of <1,500, the gel being a fluid having a storage modulus (G') which exceeds the loss modulus (G") over the entire frequency region of 0.01-10Hz when measured in an oscillatory rheometer operating at a strain 0.2.
Patent NZ-541103-A (NZ)
Title: Adhesive patchs for transdermal administration of granisetron
Inventor: ALTENSCHOPFER PETER
IPC: A61K31/439
Filed: 2004-02-05
Abstract: An adhesive patch suitable for the transdermal administration of granisetron is disclosed, wherein the adhesive is an acrylic adhesive containing non-acidic hydroxyl moieties, a physiologically effective amount of granisetron being loaded in the adhesive. These adhesive patches demonstrate a substantially increased flux of granisetron across the skin.
Patent NZ-547777-A (NZ)
Title: High pressure processing of metal ion lactoferrin as part of a sterlization method
Inventor: GONZALEZ-MARTIN MIGUEL ALEJANDRO
Filed: 2005-03-08
Abstract: Disclosed is a method of treating a composition to maintain or increase its keeping quality comprising (a) providing a composition comprising metal ion lactoferrin or a metal ion functional variant or fragment thereof and having a pH of from about 3.0 to 8.0, and (b) subjecting the composition to a pressure treatment at a treatment pressure of from about 350 MPa to about 1000 MPa to prevent the growth of unwanted microorganisms that may be present in the composition and retain at least a desired level of metal ions bound to the lactoferrin or functional variant or fragment thereof.